H.R.2821

Requires FDA to update regulations on nonclinical testing methods.

Requires the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish an interim final rule relating to nonclinical testing methods. This includes amending references to "animal" tests, data, studies, models, and research to "nonclinical" and adding the definition of "nonclinical test" to relevant sections of the Code of Federal Regulations. The interim final rule becomes effective immediately without requiring a demonstration of good cause.